| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |